Suraksha Diagnostic Share Price
332.45-7.15 (-2.11%)
+9.67% past 1 Year
Suraksha Diagnostic offers one-stop integrated solutions for pathology and radiology testing and medical consultation services including X-rays, ultrasonography, computerized tomography, magnetic resonance imaging scans and vaccination services. In addition to
Corporate filings & documents
Announcements
Please find enclosed the Newspaper Advertisement published on Monday 31st August 2026 with respect to the "Notice of 21st Annual General Meeting and e-voting information."
4 days agoPlease find enclosed the Newspaper Advertisement published on Monday 31st August 2026 with respect to the "Notice of 21st Annual General Meeting and e-voting information."
4 days agoPlease find enclosed the letter sent to those shareholders whose e-mail address are not registered providing the web link of the Companys website from where Annual Report for the Financial year 2025-26 can be accessed.
1 week agoPlease find enclosed the letter sent to those shareholders whose e-mail address are not registered providing the web link of the Companys website from where Annual Report for the Financial year 2025-26 can be accessed.
1 week agoPlease find enclosed the Notice of 21st Annual General Meeting of the Company scheduled to be held on 22nd September 2026
1 week agoPlease find enclosed the Notice of 21st Annual General Meeting of the Company scheduled to be held on 22nd September 2026
1 week agoPlease find enclosed the Annual Report of the Company for the financial year 2025-26 including Notice dated 12th August 2026 convening the 21st Annual General Meeting (AGM) of the Company scheduled to be held on 22nd September 2026.
1 week agoPlease find enclosed the Annual Report of the Company for the financial year 2025-26 including Notice dated 12th August 2026 convening the 21st Annual General Meeting (AGM) of the Company scheduled to be held on 22nd September 2026.
1 week agoNewspaper Publication for Notice of the 21st Annual General Meeting(AGM) of the Company
1 week agoNewspaper Publication for Notice of the 21st Annual General Meeting(AGM) of the Company
1 week agoNewspaper Publication for Notice of the 21st Annual General Meeting (AGM) of the Company
1 week agoNewspaper Publication for Notice of the 21st Annual General Meeting (AGM) of the Company
1 week agoThe text Transcript of Earning call held on 13 August 2026 at 11:30 a.m. (IST)with respect to the unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter ended 30 June 2026.
2 weeks agoThe text Transcript of Earning call held on 13 August 2026 at 11:30 a.m. (IST)with respect to the unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter ended 30 June 2026.
2 weeks agoIntimation of outcome of audio recording of analyst/Institutional Investor/Organizations meet-"Earning Call" which was held today i.e. 13 August 2026
3 weeks agoIntimation of outcome of audio recording of analyst/Institutional Investor/Organizations meet-"Earning Call" which was held today i.e. 13 August 2026
3 weeks agoIntimation of outcome of audio recording of Analyst/Institutional Investor/ Organizations meet-"Earning call" held today i.e. 13 Auust 2026
3 weeks agoIntimation of outcome of audio recording of Analyst/Institutional Investor/ Organizations meet-"Earning call" held today i.e. 13 Auust 2026
3 weeks agoNewspaper Publication of unaudited ( Standalone & Consolidated) Financial Results of the Company for the quarter ended 30 June 2026.
3 weeks agoNewspaper Publication of unaudited ( Standalone & Consolidated) Financial Results of the Company for the quarter ended 30 June 2026.
3 weeks agoInvestor Presentation for quarter 1 ended 30 June 2026
3 weeks agoInvestor Presentation for quarter 1 ended 30 June 2026
3 weeks agoPress release in respect of unaudited ( Standalone and Consolidated) Financial Results for the quarter ended 30 June 2026
3 weeks agoPress release in respect of unaudited ( Standalone and Consolidated) Financial Results for the quarter ended 30 June 2026
3 weeks agoRevised Record date if 15 September 2026 has been fixed
3 weeks agoRevised Record date if 15 September 2026 has been fixed
3 weeks agoAppointment of Chief Financial Officer of Mr. Dinesh Gupta
3 weeks agoAppointment of Chief Financial Officer of Mr. Dinesh Gupta
3 weeks agoApproved unaudited financial results ( Standalone and Consolidated) of the company for quarter ended 30 June 2026
3 weeks agoApproved unaudited financial results ( Standalone and Consolidated) of the company for quarter ended 30 June 2026
3 weeks agoOutcome of Board meeting held today i.e 12 August 2026
3 weeks agoOutcome of Board meeting held today i.e 12 August 2026
3 weeks agoWe wish to inform that the 21st Annual General Meeting of the Company which was scheduled to be held on Wednesday 02 September 2026 stands postponed to a future date due to certain unavoidable circumstances.
3 weeks agoWe wish to inform that the 21st Annual General Meeting of the Company which was scheduled to be held on Wednesday 02 September 2026 stands postponed to a future date due to certain unavoidable circumstances.
3 weeks agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that there will be a Conference Call viz. Earnings Call for the Analyst(s)/ Investor(s) on Thursday 13 August 2026 at 11:30 A.M. (IST)
4 weeks agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that there will be a Conference Call viz. Earnings Call for the Analyst(s)/ Investor(s) on Thursday 13 August 2026 at 11:30 A.M. (IST)
4 weeks agoSuraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoSuraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoCertificate under Regulation 74(5) of SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended 30 June 2026.
1 month agoCertificate under Regulation 74(5) of SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended 30 June 2026.
1 month agoPursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time we wish to inform you that in terms of the Companys Code of Conduct for regulating monitoring and reporting of trading by insiders the trading window for dealing in securities of the Company will remain closed for all designated persons and their immediate relatives from Wednesday 01 July 2026 and shall remain closed till 48 hours after the declaration of unaudited (standalone and consolidated) financial results of the Company for the quater ended 30 June 2026.
2 months agoPursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time we wish to inform you that in terms of the Companys Code of Conduct for regulating monitoring and reporting of trading by insiders the trading window for dealing in securities of the Company will remain closed for all designated persons and their immediate relatives from Wednesday 01 July 2026 and shall remain closed till 48 hours after the declaration of unaudited (standalone and consolidated) financial results of the Company for the quater ended 30 June 2026.
2 months agoResignation of Ms. Mamta Jain Company Secretary & Compliance Officer and Key Managerial Personnel (KMP) of the Company.
2 months agoResignation of Ms. Mamta Jain Company Secretary & Compliance Officer and Key Managerial Personnel (KMP) of the Company.
2 months agoTranscript of the Earning Call held on Friday 22 May 2026 with respect to the Audited (Standalone and Consolidated) Financial results of the Company for the quarter and year ended March 31 2026.
3 months agoTranscript of the Earning Call held on Friday 22 May 2026 with respect to the Audited (Standalone and Consolidated) Financial results of the Company for the quarter and year ended March 31 2026.
3 months agoSubmission of Annual Secretarial Complinace Report pursuant to regulations 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the financial year ended 31 March 2026.
3 months agoSubmission of Annual Secretarial Complinace Report pursuant to regulations 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the financial year ended 31 March 2026.
3 months agoIntimation of audio recording of Analysts/Institutional Investors/Organisations meet-Earnings Call
3 months agoIntimation of audio recording of Analysts/Institutional Investors/Organisations meet-Earnings Call
3 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Dec 2024
ConcallPresentation
Dec 2024
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-09-15
Dividend
0.5
Company details
Registered office
Plot No D G-12/1, Action Area 1 D Premises No 02-0327, New Town Rajarhat Kolkata West Bengal PIN: 700156 Tel No: 033-66059750 Fax No: NULL Email: [email protected] Internet: www.surakshanet.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Somnath Chatterjee, Chairman & Joint Managing Director
Somnath Chatterjee, Chairman & Joint Managing Director
Ritu Mittal, Joint Managing Director & Chief Executive Officer
Satish Kumar Verma, Non Independent & Non Executive Director
Arun Sadhanandham, Nominee Director of Orbimed Asia II Mauritius Limited
Pradip Kumar Dutta, Non Executive Independent Director
Ishani Ray, Non Executive Independent Director
Siddhartha Roy, Non Executive Independent Director
Dharam Chand Dharewa, Non Executive Independent Director
Details
BSE 544293
NSE SURAKSHA
ISIN INE877V01027